An intrinsic circadian clock of the pancreas is required for normal insulin release and glucose homeostasis in mice
- 2.4k Downloads
Loss of circadian clocks from all tissues causes defective glucose homeostasis as well as loss of feeding and activity rhythms. Little is known about peripheral tissue clocks, so we tested the hypothesis that an intrinsic circadian clock of the pancreas is important for glucose homeostasis.
We monitored real-time bioluminescence of pancreas explants from circadian reporter mice and examined clock gene expression in beta cells by immunohistochemistry and in situ hybridisation. We generated mice selectively lacking the essential clock gene Bmal1 (also known as Arntl) in the pancreas and tested mutant mice and littermate controls for glucose and insulin tolerance, insulin production and behaviour. We examined islets isolated from mutants and littermate controls for glucose-stimulated insulin secretion and total insulin content.
Pancreas explants exhibited robust circadian rhythms. Clock genes Bmal1 and Per1 were expressed in beta cells. Despite normal activity and feeding behaviour, mutant mice lacking clock function in the pancreas had severe glucose intolerance and defective insulin production; their isolated pancreatic islets had defective glucose-stimulated insulin secretion, but normal total insulin content.
The mouse pancreas has an autonomous clock function and beta cells are very likely to be one of the pancreatic cell types possessing an intrinsic clock. The Bmal1 circadian clock gene is required in the pancreas, probably in beta cells, for normal insulin secretion and glucose homeostasis. Our results provide evidence for a previously unrecognised molecular regulator of pancreatic glucose-sensing and/or insulin secretion.
KeywordsCircadian clock Glucose homeostasis Insulin Islets
Brain, muscle Arnt-like 1
KRB containing bicarbonate and HEPES
Circadian clocks are cell-autonomous molecular oscillators that drive daily rhythms of physiology and behaviour. In mammals, the clock of the suprachiasmatic nucleus (SCN) in the brain drives the rest–activity cycle and modulates physiology through autonomic and neuroendocrine control of visceral organ function . Many peripheral tissues have intrinsic clocks, but at present there is only limited information about their functions .
Mice with germ-line mutations of circadian clock function have abnormal glucose homeostasis, regardless of whether the mutation affects positive (Clock  or Bmal1 [also known as Arntl] −/− [2, 4]) or negative (Per1 −/− , Per2 −/− ) elements of the clock feedback loop. This suggests that glucose homeostasis abnormalities arise from disrupted clock function rather than from an unrelated function of a particular clock gene. Because these mice lack clock function in all tissues, abnormal glucose homeostasis could have arisen from (1) a defect of the SCN clock (and the consequent abnormal activity and feeding), (2) other brain clocks or (3) clocks of peripheral tissues. Bmal1 −/− mice have significantly reduced circulating insulin , so it is plausible that a clock within the pancreas, particularly in the insulin-producing beta cells of the islets of Langerhans, might be crucial for glucose homeostasis.
Mice (Pdx1-Cre) were provided by D. Melton (Harvard University, Department of Molecular and Cellular Biology, Cambridge, MA, USA) . We generated Bmal1 lox/lox  and Bmal1-Luc mice . Mice (hybrid C57BL/6;129 background) were entrained to a 12 h light–dark cycle for 2 weeks prior to experiments. Genotyping was performed as described . Studies were performed in accordance with a protocol approved by the Harvard Medical School Standing Committee on Animals.
Real-time recordings of circadian bioluminescence
Explants of pancreas from Bmal1-Luc circadian reporter mice were dissected, placed in medium (2 ml DMEM, supplemented with protease inhibitors, 10% [vol./vol.] FBS, 100 U/ml penicillin, 100 μg/ml streptomycin and 250 μmol/l d-luciferin), cultured and monitored for bioluminescence as described .
Glucose and insulin tolerance tests
Glucose and insulin tolerance tests, and insulin determination were performed as described . For glucose tolerance tests across the circadian cycle, manipulations were performed under dim red light.
Immunohistochemistry and in situ hybridisation
Mice with Bmal1 deleted from the pancreas (Panc-Bmal1 −/− ) and Pdx1-Cre littermates (n = 3 for each) were killed and the pancreas dissected into 4% formaldehyde in PBS. Pancreases were post-fixed (2 h, 4°C), fixative was removed by washes in PBS and tissue was cryoprotected overnight (4°C, 30% [wt/vol.] sucrose in PBS). Pancreases were then embedded and frozen, and 10 μm sections were cut on a cryostat, dried and stored at −80°C.
Insulin immunohistochemistry was performed using guinea pig anti-insulin (1:700; Dako, Glostrup, Denmark), followed by donkey anti-guinea pig secondary antibody (1:200; Invitrogen, Carlsbad, CA, USA). For double-label immunostaining with in situ hybridisation, fluorescence in situ hybridisation was performed as described in the Electronic supplementary material (ESM) Methods. Estimation of islet number was performed by counting the number of islets (identified by insulin immunostaining) per 10 μm section of four to seven sections per mouse, using three mice per genotype. Islet area and staining intensity (12–14 islets per genotype) were measured by circling islets in insulin immunofluorescence images and measuring area and mean grey value with ImageJ software (ESM Methods).
Glucose-stimulated insulin secretion
Pancreatic islets were isolated from mice and incubated overnight for recovery in DMED containing 1 mg/ml glucose (Sigma, St Louis, MO, USA) and 10% FBS. For glucose-stimulated insulin secretion, isolated islets were incubated in KRB containing bicarbonate and HEPES (KRBH; 129 mmol/l NaCl, 4.8 mmol/l KCl, 2.5 mmol/l CaCl2, 1.2 mmol/l KH2PO4, 1.2 mmol/l MgSO4, 5 mmol/l NaHCO3, 10 mmol/l HEPES, 0.1% (vol./vol.) BSA) with 2.8 mmol/l d-glucose for a 1 h for wash. Triplicates of ten islets were then incubated for 75 min in KRBH buffer containing either low (2.8 mmol/l) or high (16.7 mmol/l) d-glucose. Insulin in supernatant fractions was measured using an ELISA kit (Mouse Insulin Ultrasensitive; Alpco Diagnostics, Salem, NH, USA). For insulin content, groups of ten isolated islets were incubated overnight at −80°C in acidic ethanol (1.5% [vol./vol.] HCl in 70% [vol./vol.] ethanol), followed by centrifugation (20,000 g, 10 min) and measurement of insulin content as above.
Statistical analysis was performed by ANOVA or Student’s t test, as indicated. A value of p < 0.05 was considered significant.
We next tested the hypothesis that an intrinsic circadian clock of the pancreas is important for glucose homeostasis. To generate mice with selective genetic ablation of clock function in the pancreas (Panc-Bmal1 −/− mice), we crossed Bmal1 conditional mice  with the Pdx1-Cre line . As previously reported, Pdx1-Cre showed recombination activity throughout the pancreas and scattered activity in the duodenum, but no detectable activity in other peripheral tissues (ESM Fig. 1a). We detected no Cre activity in the SCN or in most of the brain, but did detect activity in the arcuate nucleus, ventromedial hypothalamus and dorsomedial hypothalamus (ESM Fig. 1b). Because these hypothalamic structures are well known to contribute to the neural regulation of glucose metabolism, this finding makes it essential to document a physiological defect in isolated pancreatic islets before concluding that a glucose homeostasis defect caused by Pdx1-Cre recombination is of pancreatic origin. In Panc-Bmal1 −/− mice, deletion of the conditional Bmal1 allele (ESM Fig. 2a) was consistent with the results of the indicator cross (ESM Fig. 1a). As expected, the protein brain, muscle Arnt-like 1 (BMAL1) was selectively lost from the pancreas (ESM Fig. 2b).
Unlike Bmal1 −/− mice lacking BMAL1 in all tissues , Panc-Bmal1 −/− mice exhibited normal locomotor activity, feeding behaviour, adiposity and body weight (ESM Fig. 3). Panc-Bmal1 −/− mice had an abnormality of glucose homeostasis essentially identical to that of Bmal1 −/− mice , characterised by severe glucose intolerance, normal responsiveness to insulin and defective insulin secretion in response to glucose (Fig. 1c–e). Panc-Bmal1 −/− mice exhibited intolerance to glucose throughout the circadian cycle, but a modest circadian modulation of glucose tolerance similar to that of controls persisted (Fig. 1f, g). Thus at least one clock outside the pancreas contributes to the circadian regulation of circulating glucose. The most likely candidate is the SCN clock, thought to modulate insulin secretion or sensitivity via autonomic efferents .
Previous reports of clock gene expression in the pancreas  and rhythmic insulin release from isolated islets  suggested that a pancreatic clock regulates glucose homeostasis in vivo, a hypothesis our experiments have explicitly tested. Our results indicate that the Bmal1 gene, and probably circadian clock function, is required in the pancreas for normal insulin secretion and normal glucose homeostasis. The glucose intolerance of Panc-Bmal1 −/− mice is essentially identical to that of Bmal1 −/− mice , indicating that the loss of SCN clock function and consequent behavioural abnormalities in Bmal1 −/− mice contribute little, if anything to the glucose homeostasis phenotype. A similar, independent analysis has recently been reported .
We do not know the molecular mechanism underlying the defect in insulin release in Panc-Bmal1 −/− mice. The known role of clocks in regulating cell-autonomous gene expression suggests that a circadian clock within pancreatic beta cells regulates levels of one or more proteins of the glucose-sensing and/or insulin secretion pathways. In the absence of BMAL1, levels of one or more such proteins might fall below the usual circadian trough value, limiting insulin secretion. Our results provide evidence for a previously-unrecognised molecular regulator of pancreatic glucose-sensing and/or insulin secretion.
We thank D. Melton (Harvard University, Cambridge, MA, USA) for Pdx1-Cre mice, B. Lowell and D. Kong (Beth Israel Deaconess Medical Center, Boston, MA, USA) for advice and M. Liu (Department of Neurobiology, Harvard Medical School, Boston, MA, USA) for technical assistance. This work was supported by NIH grant R01 NS060860 (to C. J. Weitz), a Merck Fellowship of the Life Sciences Research Foundation (to K. A. Lamia), a Training Program in Sleep, Circadian and Respiratory Neurobiology Pre-Doctoral Fellowship T32 HL07901 (to L. A. Sadacca), and a Research Training in Digestive Diseases Fellowship T32 DK07191 (to A. S. deLemos). B. Blum is supported by an EMBO long-term post-doctoral fellowship.
Duality of interest
The authors declare that there is no duality of interest associated with this manuscript.
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.